Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treatment of recurrent hematological malignancies

Methods for treatment of recurrent hematological malignancies

US Patent 9844593 · Granted Dec 19, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2024
Treatment regimens using anti-NKG2A antibodies2024
Treatment of peripheral T cell lymphoma2024
Neutralization of inhibitory pathways in lymphocytes2023
Treatment of cancers using anti-NKG2A agents2022
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2021
Neutralization of inhibitory pathways in lymphocytes2020
Neutralization of inhibitory pathways in lymphocytes2020
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer2020
Treatment regimens using anti-NKG2A antibodies2020
Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma2019
Treatment of peripheral T cell lymphoma2019